phloretin has been researched along with Ischemia in 1 studies
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shelke, V | 1 |
| Kale, A | 1 |
| Dagar, N | 1 |
| Habshi, T | 1 |
| Gaikwad, AB | 1 |
1 other study available for phloretin and Ischemia
| Article | Year |
|---|---|
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury.
Topics: Acute Kidney Injury; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ischemia; Mal | 2023 |